DIFFERENT EFFECTS OF ANTIHYPERTENSIVE THERAPIES BASED ON LOSARTAN OR ATENOLOL ON ULTRASOUND AND BIOCHEMICAL MARKERS OF MYOCARDIAL FIBROSIS | Publicación